BRVE

20.3905.81%
ND

Natalie Dement

VP & Head of Legal

Ms. Natalie Dement, J.D., is Vice President and Head of Legal at Braveheart Bio, Inc. since November 2025. She has experience practicing law, half of which has been in-house at early and growth stage biotechnology companies. She began her career as an M&A attorney in the Palo Alto offices of White & Case LLP where she supplemented her M&A practice with venture financing and pharmaceutical licensing. Following White & Case, she continued her M&A practice in-house at Wells Fargo Bank. Desiring to combine her corporate law background with her love for biology, she moved to Zymergen Inc., where she managed their IPO in 2021. She has since held senior roles at Mammoth Biosciences Inc. and Human Immunology Biosciences (HI-Bio), Inc. She received her law degree from Emory University School of Law and her undergraduate degree in Human Biology from Stanford University.

Positions